Medicare Enrolled

Dr. Alexandra Fingesten, MD

Optician · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
145 E 32ND ST FL 6, New York, NY 10016
2128894360
In practice since 2007 (19 years)
NPI: 1972658185 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fingesten from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fingesten? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fingesten

Dr. Alexandra Fingesten is an optician specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fingesten performed 2,407 Medicare services across 1,354 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fingesten received a total of $8,139 from 37 pharmaceutical and/or device companies across 480 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fingesten is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 32% volume in NY $8,139 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,407
Medicare services
Top 32% in NY for optician
1,354
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~127 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
575 $8 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
542 $100 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
539 $64 $300
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
173 $149 $150
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
170 $1 $10
Quadrivalent influenza vaccine, cell culture-derived
A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods.
104 $29 $30
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
87 $3 $15
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
60 $146 $448
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
50 $12 $200
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
38 $49 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
32 $136 $434
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
21 $190 $200
New patient office visit, complex (60-74 min) 16 $203 $525
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,139
Total received (2018-2024)
Avg $1,163/year across 7 years
Top 17% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
480
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,139 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,792
2023
$1,558
2022
$1,370
2021
$1,576
2020
$1,177
2019
$358
2018
$308

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$334
ABBVIE INC.
$312
GlaxoSmithKline, LLC.
$211
Alkermes, Inc.
$208
Teva Pharmaceuticals USA, Inc.
$134
Lilly USA, LLC
$102
Axsome Therapeutics, Inc.
$90
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$77
Amgen Inc.
$74
USWM, LLC
$59
AstraZeneca Pharmaceuticals LP
$50
Eisai Inc.
$45
Neurocrine Biosciences, Inc.
$25
Almatica Pharma LLC
$25
Bausch Health US, LLC
$17
Otsuka America Pharmaceutical, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 47.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,373
Alkermes, Inc.
$820
AbbVie Inc.
$774
GlaxoSmithKline, LLC.
$744
Novo Nordisk Inc
$576
AstraZeneca Pharmaceuticals LP
$514
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$456
Allergan, Inc.
$323
Bausch Health US, LLC
$298
PFIZER INC.
$259
Lilly USA, LLC
$208
Janssen Pharmaceuticals, Inc
$205
Amgen Inc.
$176
Supernus Pharmaceuticals, Inc.
$156
Eisai Inc.
$140
Teva Pharmaceuticals USA, Inc.
$134
Takeda Pharmaceuticals U.S.A., Inc.
$117
Radius Health, Inc.
$90
Axsome Therapeutics, Inc.
$90
Astellas Pharma US Inc
$89
US WorldMeds, LLC
$79
E.R. Squibb & Sons, L.L.C.
$72
USWM, LLC
$59
Gilead Sciences, Inc.
$57
Otsuka America Pharmaceutical, Inc.
$41
Allergan Inc.
$40
Scilex Pharmaceuticals Inc.
$40
Ironwood Pharmaceuticals, Inc
$39
Neurocrine Biosciences, Inc.
$25
Almatica Pharma LLC
$25
Corium, LLC
$22
Biohaven Pharmaceuticals, Inc.
$21
IRONWOOD PHARMACEUTICALS, INC
$21
Circassia Pharmaceuticals Inc
$16
ACADIA Pharmaceuticals Inc
$14
Kowa Pharmaceuticals America, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 36.5% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · APLENZIN · AZSTARYS · Austedo XR · Auvelity · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · COLOGUARD · CREON · Dayvigo · ELIQUIS · EMGALITY · EVENITY · FARXIGA · FASENRA · INGREZZA · JANUVIA · LINZESS · LIVALO · LOREEV XR · Leqembi · Linzess · Lucemyra · Lucemyra/Lofexidine · MOTEGRITY · MOUNJARO · MYRBETRIQ · NUPLAZID · NURTEC ODT · Otezla · Ozempic · PREMARIN · Prolia · QELBREE · QULIPTA · REXULTI · Repatha · Rybelsus · SYMBICORT · Saxenda · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TUDORZA PRESSAIR · Tymlos · UBRELVY · VIBERZI · VIIBRYD · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · Vivitrol 380 mg · Wegovy · XARELTO · XIFAXAN · ZEPBOUND · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in New York?
Compare opticians in the New York area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
15,419
Per 100K population
947.2
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fingesten is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fingesten experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Fingesten performed 575 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fingesten receive payments from pharmaceutical companies?
Yes. Dr. Fingesten received a total of $8,139 from 37 companies across 480 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fingesten's costs compare to other opticians in New York?
Dr. Fingesten's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fingesten) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →